2Heijer MD,Koster T,Blom HJ.Hyperhomocysteinemia as a risk factor for deep-vein thrombosis[J].N Engl J Med,1996,334:759.
3Ungvarl SJ,Arkedi E,Zsolt B,et al.Simultaneously increased TXA2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia arteriosclerosis[J].Thromb Vase Biod,2000,20:1203.
1[1]Brandenburg SL,Reusch JE,Felder KK.Impaired fibri-nolysis in premenopausal women and age-matched men with type 2 diabetes mellitus:a pilot study[J].J Investig Med,2002,50(2):110
2[2]Yamada T,Sato A,Nishimori T,et al.Importance of hypercoagulability over hyperglycemia for vascular compli-cation in type 2 diabetes[J].Diabetes Res Clin Pract,2000,49(1):23.
3[3]Olexa P,Olexova M.Plasminogen activator inhibitor1 is chemic heart disease and diabetes mellitus[J].Vnitr Lek,2003,49 (3):222-226.
4Russell R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
5Mueck AO, Seeger H. Statins and direct vascular actions. Panminerva Med, 2003, 45: 1-6.
6Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on P
7Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol, 2000,36: 95
8Tsiara S, Elisaf M, Mikhailidis DP. Early vascular benefits of statin therapy. Curr Med Res Opin, 2003, 19: 540-556.
9Hashimoto M, Akita H. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation, 2002, 105: E30-E31.
10Ridker PM, Rifai N, Pfeffer MA, et al. Long term effects of pravastatin on plasma concentrations of C-reactive protein. The Cholesterol and Recurrent Events. (CARE) investigators. Circulation, 2000, 100: 230-235.
